Aquestive is interested in assets which are complementary to our existing pipeline products in CNS, although we will consider products that meet our criteria in adjacent therapy areas. Typically, we look to in-license products for which most clinical trials have been conducted and which are either in the process of registration or are already registered and ready to commercialize. Our assessment processes for in-licensing opportunities are led by our business development team, supported by expertise from other functional areas of the business.
Aquestive partners commercialize hundreds of millions of doses of PharmFilm every year. We partner to deliver novel molecules in clinical development and to repurpose approved medications for the benefit of patients and caregivers. Aquestive maintains a robust and fully integrated infrastructure for managing
projects from inception to commercial supply.
Aquestive has a strong culture of alliance management driven by the belief that we are only as successful as our partners. We engage with partner companies to determine the suitability of the molecule, dosage strength, and chosen route of administration.